LabGenomics Co., Ltd. (KOSDAQ:084650)
1,831.00
-74.00 (-3.88%)
Nov 3, 2026, 1:39 PM KST
LabGenomics Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 77,640 | 88,161 | 85,898 | 71,076 | 144,773 | 202,407 |
Revenue Growth | -11.74% | 2.63% | 20.85% | -50.91% | -28.48% | 69.41% |
Gross Profit Gross Profit Growth | 25,464 | 29,375 | 30,184 | 29,499 | 96,121 | 124,886 |
Operating Income Operating Income Growth | -40,080 | -54,917 | -18,491 | -6,923 | 66,206 | 104,518 |
Net Income Net Income Growth | -51,595 | -64,375 | -23,796 | -4,674 | 48,397 | 83,855 |
Earnings Per Share EPS Growth | -3770.08 | -4335.57 | -1602.64 | -314.78 | 3572.50 | 6202.50 |
EPS Growth | - | - | - | - | -42.40% | 91.05% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 25,714 | 34,797 | 34,563 | 50,391 | 129,301 | 131,898 |
Europe Europe Growth | 759.65 | 511.75 | 326.38 | 498.99 | 776.93 | 1,397 |
America America Growth | 51,109 | 52,792 | 50,858 | 21,575 | 2,773 | 1,324 |
Asia Asia Growth | 57.39 | 60.26 | 122.06 | 661.34 | 11,830 | 61,335 |
Other Other Growth | - | - | 45.23 | - | 91.79 | 6,454 |
Total Total Growth | 77,640 | 88,161 | 85,914 | 73,127 | 144,773 | 202,407 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 36,716 | 58,019 | 90,864 | 115,391 | 136,971 | 98,998 |
Total Debt Total Debt Growth | 62,560 | 55,499 | 50,202 | 49,994 | 21,228 | 5,321 |
Net Cash (Debt) Net Cash Growth | -25,844 | 2,520 | 40,662 | 65,396 | 115,743 | 93,678 |
Net Cash Growth | - | -93.80% | -37.82% | -43.50% | 23.55% | 96.42% |
Net Cash Per Share Net Cash Per Share Growth | -1740.57 | 169.72 | 2738.57 | 4404.39 | 8545.71 | 6930.30 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -25,501 | -30,536 | -12,995 | -3,827 | 68,955 | 65,362 |
Capital Expenditures CapEx Growth | -1,288 | -1,138 | -3,669 | -4,990 | -37,648 | -13,717 |
Free Cash Flow Free Cash Flow Growth | -26,789 | -31,674 | -16,663 | -8,817 | 31,307 | 51,645 |
Free Cash Flow Growth | - | - | - | - | -39.38% | 13.08% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.80% | 33.32% | 35.14% | 41.50% | 66.39% | 61.70% |
Operating Margin | -51.62% | -62.29% | -21.53% | -9.74% | 45.73% | 51.64% |
Pretax Margin | -56.06% | -68.35% | -30.21% | -10.04% | 43.79% | 53.92% |
Profit Margin | -66.45% | -73.02% | -27.70% | -6.58% | 33.43% | 41.43% |
FCF Margin | -34.50% | -35.93% | -19.40% | -12.40% | 21.63% | 25.52% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 4.43 | 3.35 |
P/FCF Ratio | - | - | - | - | 6.84 | 5.44 |
PS Ratio | 0.36 | 1.53 | 2.15 | 4.03 | 1.48 | 1.39 |